Simcere Pharmaceutical Group Limited
Simcere Pharmaceutical Group Limited engages in the research, development, manufacture, and sale of pharmaceutical products for distributors and pharmacy chains and other pharmaceutical manufacturers in China. It focusses on various therapeutic areas, in…
Biotechnology
CN, Nanjing [HQ]
2096.HK/Financial Reporting
Income Statements
Profit & Loss · 8 Statements · From 2023 to 2012Configuration
In Million CNY. Margins, Growth Rates In %
| Metric | 2012 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2,082.00 | 3,867.00 | 4,514.00 | 5,036.00 | 4,508.00 | 4,999.00 | 6,319.00 | 6,607.00 | |
|
EPS
|
0.53 | 0.13 | 0.28 | 0.39 | 0.26 | 0.58 | 0.40 | 0.27 | |
| Diluted in mil. | 0.53 | 0.13 | 0.28 | 0.39 | 0.26 | 0.58 | 0.40 | 0.27 | |
|
Profit
|
1,721.00 | 3,281.00 | 3,743.00 | 4,148.00 | 3,608.00 | 3,919.00 | 4,996.00 | 4,984.00 | |
| Gross Margin | 82.67 | 84.84 | 82.92 | 82.36 | 80.04 | 78.40 | 79.08 | 75.43 | |
| Pre Tax | -19.00 | 497.00 | 929.00 | 1,081.00 | 805.00 | 1,401.00 | 888.00 | 740.00 | |
| Profit Margin | -0.96 | 12.86 | 20.58 | 21.48 | 17.86 | 28.04 | 14.06 | 11.20 | |
| ETR | -27.93 | 29.53 | 21.03 | 7.23 | 17.49 | -6.93 | -4.56 | 3.53 | |
| Net | 56.00 | 350.00 | 733.00 | 1,003.00 | 669.00 | 1,507.00 | 930.00 | 714.00 | |
| Profit Margin | 2.73 | 9.06 | 16.25 | 19.93 | 14.85 | 30.14 | 14.73 | 10.82 | |
| EBITDA | 227.00 | 825.00 | 1,015.00 | 1,342.00 | 787.00 | 939.00 | 1,088.00 | 1,090.00 | |
| EBITDA Margin | 10.94 | 21.34 | 22.50 | 26.66 | 17.48 | 18.80 | 17.23 | 16.51 | |
| Operating Income | 96.00 | 530.00 | 941.00 | 1,171.00 | 565.00 | 687.00 | 862.00 | 711.00 | |
| Operating Margin | 4.63 | 13.72 | 20.87 | 23.26 | 12.55 | 13.76 | 13.65 | 10.77 | |
| Interest Income | - - | 25.00 | 36.00 | 34.00 | 26.00 | 68.00 | 59.00 | 54.00 | |
| Loss | -2,037.00 | -3,166.00 | -3,674.00 | -3,896.00 | -3,918.00 | -4,783.00 | -5,742.00 | -5,881.00 | |
| Cost of Revenue | -361.00 | -586.00 | -771.00 | -888.00 | -899.00 | -1,079.00 | -1,322.00 | -1,623.00 | |
|
Operating Expenses
|
-1,676.00 | -2,580.00 | -2,903.00 | -3,008.00 | -3,018.00 | -3,703.00 | -4,420.00 | -4,257.00 | |
| R&D | -228.00 | -212.00 | -447.00 | -716.00 | -1,141.00 | -1,416.00 | -1,728.00 | -1,563.00 | |
| G&A | -255.00 | -126.00 | -129.00 | -142.00 | -411.00 | -382.00 | -444.00 | -487.00 | |
| SG&A | -1,396.00 | -2,282.00 | -2,351.00 | -2,158.00 | -1,981.00 | -2,419.00 | -2,846.00 | -2,844.00 | |
| S&M | -1,140.00 | -2,155.00 | -2,221.00 | -2,016.00 | -1,570.00 | -2,036.00 | -2,402.00 | -2,356.00 | |
| Depreciation and Amortization | -131.00 | -104.00 | -120.00 | -162.00 | -222.00 | -251.00 | -282.00 | -309.00 | |
| Interest Expenses | -81.00 | -58.00 | -47.00 | -115.00 | -133.00 | -70.00 | -34.00 | -34.00 | |
| Other Expenses | -116.00 | -251.00 | -88.00 | -89.00 | -239.00 | -713.00 | -25.00 | -7.00 | |
|
WA Shares Outstanding
|
107.00 | 2,605.00 | 2,605.00 | 2,605.00 | 2,608.00 | 2,608.00 | 2,611.00 | 2,608.00 | |
| Diluted | 107.00 | 2,605.00 | 2,605.00 | 2,605.00 | 2,608.00 | 2,611.00 | 2,620.00 | 2,608.00 |